BA
47
2
AMAT
33
-13
STX
45
-4
CAH
48
-6
OMC
50
-16
WMT
56
-4
GM
74
5
MAS
52
-4
COP
57
-2
MS
77
-2
GRMN
67
-4
PFE
14
-7
ALLE
37
-4
HSY
31
-6
KMX
61
-3
PYPL
52
-2
ILMN
32
-9
IR
63
-3
SPG
60
2
A
37
-2
BA
47
2
AMAT
33
-13
STX
45
-4
CAH
48
-6
OMC
50
-16
WMT
56
-4
GM
74
5
MAS
52
-4
COP
57
-2
MS
77
-2
GRMN
67
-4
PFE
14
-7
ALLE
37
-4
HSY
31
-6
KMX
61
-3
PYPL
52
-2
ILMN
32
-9
IR
63
-3
SPG
60
2
A
37
-2
Financhill
Back

AdvisorShares Pure US Cannabis ETF Vs. Neurogene Industry Stock Comparison

Sell
20

MSOS
AdvisorShares Pure US Cannabis ETF

Last Price:
5.06
Seasonality Move:
11.29%
Sell
1

NGNE
Neurogene

Last Price:
34.67
Seasonality Move:
50.43%
Sell
20
AdvisorShares Pure US Cannabis ETF (MSOS) is a Sell

Is AdvisorShares Pure US Cannabis ETF a Buy, Sell or Hold?

  • The current AdvisorShares Pure US Cannabis ETF [MSOS] share price is $5.06. The Score for MSOS is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • MSOS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
1
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

MSOS Stock Price Chart

What is AdvisorShares Pure US Cannabis ETF's stock price today?

  • The AdvisorShares Pure US Cannabis ETF share price today is $5.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MSOS is experiencing buying pressure, which is a positive indicator for future bullish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $34.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

MSOS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.6 Sell
Relative Strength Index (14 RSI): 39.25 Sell
Chaikin Money Flow: 9811496 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.31 - 7.51) Sell
Bollinger Bands (100): (6.21 - 7.65) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 35.74 Sell
Chaikin Money Flow: -452975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.4 - 61.5) Sell
Bollinger Bands (100): (34.32 - 50.52) Sell

MSOS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.88 Buy
20-day SMA: 6.25 Sell
50-day SMA: 6.68 Sell
200-day SMA: 7.89 Sell
8-day EMA: 5.18 Sell
20-day EMA: 5.86 Sell
50-day EMA: 6.47 Sell
200-day EMA: 7.32 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.3 Sell
20-day SMA: 51.47 Sell
50-day SMA: 46.76 Sell
200-day SMA: 38.99 Sell
8-day EMA: 47.13 Sell
20-day EMA: 50.2 Sell
50-day EMA: 47.47 Sell
200-day EMA: 38.44 Sell

AdvisorShares Pure US Cannabis ETF Earnings Growth & MSOS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

AdvisorShares Pure US Cannabis ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):